Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News CyanVac’s nasal COVID-19 vaccine shows strong immune response in U.S. phase 1 clinical trial CyanVac’s nasal COVID-19 vaccine shows strong mucosal immune response in U.S. phase 1 trial. Larger studies underway to assess full efficacy. byPallavi MadhirajuJuly 5, 2025